HTG MOLECULAR DIAGNOSTICS, INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Htg Molecular Diagnostics, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q1 2023.
  • Htg Molecular Diagnostics, Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $893K, a 28.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $893K -$352K -28.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.01M -$338K -25.1% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $1.04M -$404K -28% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.14M +$897K +364% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.25M +$896K +257% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.35M +$336K +33.3% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.44M +$698K +93.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $246K -$659K -72.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $349K -$690K -66.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.01M -$200K -16.5% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $746K -$624K -45.5% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $905K -$489K -35.1% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $1.04M +$418K +67.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.21M Dec 31, 2019 10-K 2021-03-25
Q3 2019 $1.37M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.39M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $621K Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.